These results are consistent with many previously published studies proposed that GJB1 and JAG1 associated significantly with the development of distant metastasis [38], while COL9A1 and FGF2 mutation associated with drug resistance in breast cancer patients [39, 40]. This evidence concerns the gene FGF2 and breast carcinoma.